These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11416802)
61. New approaches to lung cancer prevention. McWilliams A; Lam S Curr Oncol Rep; 2002 Nov; 4(6):487-94. PubMed ID: 12354360 [TBL] [Abstract][Full Text] [Related]
62. Chemoprevention of lung cancer: new directions. Szabo E; Kalebic T Recent Results Cancer Res; 2003; 163():172-81; discussion 264-6. PubMed ID: 12903853 [TBL] [Abstract][Full Text] [Related]
63. [Protection against tobacco smoke--compounds and substances of natural orgin]. Budzianowska A; Budzianowski J Przegl Lek; 2015; 72(3):148-51. PubMed ID: 26731873 [TBL] [Abstract][Full Text] [Related]
64. Opportunities and Challenges of Kava in Lung Cancer Prevention. Freeman B; Mamallapalli J; Bian T; Ballas K; Lynch A; Scala A; Huo Z; Fredenburg KM; Bruijnzeel AW; Baglole CJ; Lu J; Salloum RG; Malaty J; Xing C Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298489 [TBL] [Abstract][Full Text] [Related]
65. [The efficacy of the politics of prevention and screening in the fight against cancer]. Tratner I Med Sci (Paris); 2003 Mar; 19(3):368-70. PubMed ID: 12836421 [No Abstract] [Full Text] [Related]
70. Ashes to ashes: the significance of preventing lung cancer through primary prevention and health promotion. Booker R Can Oncol Nurs J; 2000; 10(2):69-73. PubMed ID: 11022441 [No Abstract] [Full Text] [Related]
71. Diet, natural products and cancer chemoprevention. Singletary K J Nutr; 2000 Feb; 130(2S Suppl):465S-466S. PubMed ID: 10721930 [TBL] [Abstract][Full Text] [Related]
72. Carotenoids for lung cancer chemoprevention and chemotherapy: Promises and controversies. Varghese R; Efferth T; Ramamoorthy S Phytomedicine; 2023 Jul; 116():154850. PubMed ID: 37187036 [TBL] [Abstract][Full Text] [Related]
73. Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies. Howells LM; Mahale J; Sale S; McVeigh L; Steward WP; Thomas A; Brown K J Pharmacol Exp Ther; 2014 Sep; 350(3):483-94. PubMed ID: 24939419 [TBL] [Abstract][Full Text] [Related]
74. General Aspects of Primary Cancer Prevention. Krstic MN; Mijac DD; Popovic DD; Pavlovic Markovic A; Milosavljević T Dig Dis; 2019; 37(5):406-415. PubMed ID: 30783074 [TBL] [Abstract][Full Text] [Related]
75. Personalizing lung cancer prevention through a reverse migration strategy. Gold KA; Kim ES; Wistuba II; Hong WK Top Curr Chem; 2013; 329():221-40. PubMed ID: 22752582 [TBL] [Abstract][Full Text] [Related]
76. Cancer Prevention: Obstacles, Challenges and the Road Ahead. Meyskens FL; Mukhtar H; Rock CL; Cuzick J; Kensler TW; Yang CS; Ramsey SD; Lippman SM; Alberts DS J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547931 [TBL] [Abstract][Full Text] [Related]
77. Additional clues to lung cancer risk. Shaw GL Cancer Invest; 1999; 17(8):661-2. PubMed ID: 10592773 [No Abstract] [Full Text] [Related]
78. Consensus statement on lung cancer. Lung Cancer Panel. Biesalski HK; Bueno de Mesquita B; Chesson A; Chytil F; Grinble R; Hermus RI; Köhrle J; Lotan R; Norpoth K; Pastorino U; Thurnham D Eur J Cancer Prev; 1997 Aug; 6(4):316-22. PubMed ID: 9370093 [No Abstract] [Full Text] [Related]
79. Chemoprevention of lung cancer. Witschi H Methods Mol Med; 2003; 75():739-54. PubMed ID: 12407776 [No Abstract] [Full Text] [Related]
80. [Lung cancer in Spain: the current situation. 2008 SESPAS Report]. Bonfill X; Puig MT; Bolívar I; Quintana MJ Gac Sanit; 2008 Apr; 22 Suppl 1():169-78. PubMed ID: 18405567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]